- JP-listed companies
- KOBAYASHI PHARMACEUTICAL CO.,LTD.
- Income statement
KOBAYASHI PHARMACEUTICAL CO.,LTD.【JP:4967】Income statement
Market cap
¥428.3B
P/E ratio
38.9x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 131,166 | 121,532 | 127,293 | 128,344 | 137,211 | 120,051 | 156,761 | 167,479 | 168,052 | 150,514 | 155,252 | 166,258 | 173,455 | 165,600 |
| Cost of revenue | - | - | - | 54,718 | 57,518 | 48,638 | 61,238 | 64,359 | 64,705 | 65,248 | 66,478 | 73,927 | 77,079 | 77,997 |
| Gross profit | - | - | - | 73,626 | 79,693 | 71,412 | 95,522 | 103,119 | 103,346 | 85,265 | 88,773 | 92,331 | 96,375 | 87,603 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 17,917 | 18,260 | 17,409 | 22,925 | 26,289 | 26,355 | 25,943 | 26,065 | 26,669 | 25,780 | 24,860 |
| Operating expenses | - | - | - | 55,708 | 61,432 | 54,003 | 72,596 | 76,830 | 76,991 | 59,322 | 62,707 | 65,662 | 70,595 | 62,742 |
| Income before tax | 20,092 | 18,677 | 18,769 | 18,843 | 17,949 | 19,499 | 24,191 | 27,374 | 27,851 | 27,726 | 28,015 | 28,281 | 27,330 | 26,861 |
| Provision for income taxes | - | - | - | 7,608 | 5,300 | 5,544 | 6,709 | 7,280 | 7,665 | 7,430 | 7,920 | 7,927 | 7,221 | 3,842 |
| Net income | 9,981 | 12,849 | 10,804 | 12,448 | 13,466 | 14,321 | 15,863 | 18,023 | 19,139 | 19,205 | 19,715 | 20,022 | 20,338 | 10,071 |
| Earnings per share | 286.36 | 297.37 | 300.55 | 305.46 | 331.11 | 179.12 | 201.31 | 228.05 | 244.08 | 245.71 | 252.36 | 259.63 | 268.16 | 135.42 |
| Diluted EPS | - | - | - | - | 330.6 | 178.86 | 201.03 | 227.95 | - | - | - | 259.59 | - | - |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| Dividend per share | 78 | 82 | 86 | 90 | 96 | 52 | 58 | 66 | 73 | 77 | 83 | 90 | 101 | 102 |